statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ClearPoint Neuro (NASDAQ:CLPT  Get Free Report) and Nephros (NASDAQ:NEPH  Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the...

Comparing Nephros (NASDAQ:NEPH) and ClearPoint Neuro (NASDAQ:CLPT)

Nephros (NASDAQ:NEPH  Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, Zacks reports. The firm had...

Nephros (NASDAQ:NEPH) Releases  Earnings Results

Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript...

Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Nephros just upgraded at Benchmark, here's why

Nephros: Q4 Earnings Insights

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a...

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Volume	7,314.00
52-Wk High	$4.04
52-Wk Low	$1.13

NEPH Nephros Inc

About

Feed

News

Earnings

Fundamentals